Results 91 to 100 of about 10,466,444 (219)

How young people find out about their family history of Huntington's disease [PDF]

open access: yes, 2009
Family communication about adult-onset hereditary illness can be problematic, leaving some relatives inadequately informed or ignorant of their risk.
Forrest Keenan, Karen   +4 more
core   +1 more source

Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

open access: yesJournal of Neuroscience, 1999
Transgenic mice expressing exon 1 of the human Huntington’s disease (HD) gene carrying a 141–157 CAG repeat (line R6/2) develop a progressive neurological phenotype with motor symptoms resembling those seen in HD. We have characterized the motor deficits
Rebecca J. Carter   +8 more
semanticscholar   +1 more source

Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries. [PDF]

open access: yes, 2016
We identified drug seeds for treating Huntington's disease (HD) by combining in vitro single molecule fluorescence spectroscopy, in silico molecular docking simulations, and in vivo fly and mouse HD models to screen for inhibitors of abnormal ...
Chen, Xigui   +17 more
core   +2 more sources

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease

open access: yesExperimental and Molecular Medicine, 2019
Huntington’s disease: Diabetes drug limits disease-related degeneration in mice Metformin, an existing drug for diabetes, shows promise in alleviating symptoms of early Huntington’s disease in mouse models. Huntington’s disease is a genetic disorder that
Ana Sanchis   +6 more
doaj   +1 more source

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

open access: yesCell, 2000
Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates.
Ai Yamamoto, J. Lucas, R. Hen
semanticscholar   +1 more source

The kabod Spring 2016 [PDF]

open access: yes, 2016
Completed issue of article publications for Spring ...

core   +1 more source

Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1 [PDF]

open access: yes, 2002
The toxicity of an abnormally long polyglutamine [poly(Q)] tract within specific proteins is the molecular lesion shared by Huntington's disease (HD) and several other hereditary neurodegenerative disorders.
Benzer, Seymour, Kazemi-Esfarjani, Parsa
core   +1 more source

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients. [PDF]

open access: yes, 2015
Quantification of disease-associated proteins in the cerebrospinal fluid (CSF) has been critical for the study and treatment of several neurodegenerative disorders; however, mutant huntingtin protein (mHTT), the cause of Huntington's disease (HD), is at ...
Andreas Weiss   +16 more
core   +1 more source

Diagnosing Juvenile Huntington’s Disease: An Explorative Study among Caregivers of Affected Children

open access: yesBrain Sciences, 2020
Objective: To investigate the reasons for the diagnostic delay of juvenile Huntington’s disease patients in the Netherlands. Methods: This study uses interpretative phenomenological analysis.
Mayke Oosterloo   +3 more
doaj   +1 more source

Huntingtons sykdom - Symptombeskrivelse i faglitteratur og skjønnlitteratur [PDF]

open access: yes, 2010
Huntington’s disease is a genetic neurodegenerative disorder that affects a person’s body, mind and behavior. The disease has been portrayed in several works of fiction.
Moldekleiv, Hanna Helena
core  

Home - About - Disclaimer - Privacy